Genetic tests provide actionable results and guide
important and time sensitive health decisions
Admera Health’s Clinical Decision Support System
- Gain digital access to all patients’ PGxOne™ Plus results even without an EMR integration
- Easily navigate test results with dynamic searches, including by medication, therapeutic area, and drug interactions
- Securely and easily refer a patient’s report to another physician
Everyone responds to
medications differently
Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics
Everyone responds to
medications differently
Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics
Over 50 genes | Over 200 variants
A courtesy consultation with experts in the field of pharmacogenomics is available Monday through Friday 8am to 8pm EST at 
844-4ADMERA (844.423.6372)
What is Pharmacogenomics?
PGxOne™ Plus provides actionable reporting
The PGxOne™ Plus report provides gene, genotype, and PGx related phenotype information providing an additional tool to manage patient care.
LiquidGx
Non-invasive cancer testing for identifying
actionable mutations and treatment
monitoring from a blood sample.
OncoGxOne™ – Solid Tumor Profiling
Tumor profiling for targeted therapy selection. Choose between a panel aligned with national treatment guidelines or a comprehensive panel.
AtheroGxOne™
Detects genetic variants responsible
for diseases that can cause early
atherosclerosis.
CardioGxOne™
Detects genetic variants responsible for over 30 inherited cardiovascular diseases included cardiomyopathies, arrhythmias, and aortic vascular diseases.
1
Provide a buccal swab,
mouth wash, blood,
or saliva sample
2
Ship the
specimen to
Admera Health
3
Admera Health
scientists sequence
and interpret DNA
4
Receive a
personalized
genetic report
